Reply to: “Usefulness of Lead-In phase in determining risk/benefit of telaprevir treatment in patients with HCV cirrhosis”

• 期刊名称Journal of Hepatology
• 作者Foster, Graham R.
• 卷第58卷
• 期第6期
• 印刷ISSN0168-8278
• 文件大小170.38KB
• 发表时间2013-06
• DOI10.1016/j.jhep.2013.01.027